Sight Sciences Inc. (SGHT): Market Cap to Revenue

Symbol and logo of brand Sight Sciences Inc. (SGHT)

Sight Sciences, Inc. (SGHT) is implementing eco-friendly standards in the production of ophthalmological equipment by reducing plastic usage. The price-to-sales ratio visualizes the dynamics of this process, where the 6.80 level indicates the status of the parameter. Stable demand is driven by the unique ergonomics of its microsurgical instruments. Meanwhile, Sight Sciences, Inc. (SGHT) is mitigating regulatory risks in the glaucoma treatment segment through the systematic training of physicians in new methodologies.

SGHT Sight Sciences Inc. P/S Multiple (07/04/2022 - 11/14/2026)

Analytical breakdowns for sightsciences.com (SGHT)

- share price and consensus valuation forecast:
Price Performance Chart Sight Sciences Inc.|SGHT - Price Target Chart
- stock exchange capitalization data:
Market Valuation Sight Sciences Inc|SGHT - Enterprise Value
- book value of equity indicators:
Net Asset Value per Share Sight Sciences, Inc.|SGHT - Book Capitalization|Capitalization to Book Value Ratio sightsciences.com|SGHT - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient Sight Sciences, Inc.|SGHT - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Sight Sciences, Inc.|SGHT - Company Aggregate Debts|Debts to Book Capitalization Sight Sciences, Inc.|SGHT - Company Long-Term Debt|Company Short-Term Debt Sight Sciences, Inc.|Intermediate Coverage Ratio sightsciences.com
- earnings and multiples data:
SGHT - Net Profit|Expected Net Profit Sight Sciences, Inc.|SGHT - Price to Earnings Ratio|Forward Price to Earnings Multiple Sight Sciences, Inc.|SGHT - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Sight Sciences Inc|SGHT - Operating profit EBITDA|Net earnings per share for the last four quarters Sight Sciences, Inc.|SGHT - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months sightsciences.com|SGHT - Earnings per share growth in current year|Expected earnings per share growth for next year Sight Sciences, Inc.
- issuer revenue and sales details:
SGHT - Revenue and Sales Volume|Company Expected Sales Volume Sight Sciences Inc.|SGHT - Price-to-Revenue Ratio|Market Cap to Projected Revenue Sight Sciences
General company analysis:SGHT Sight Sciences Inc.
Core merchandise of Sight Sciences, Inc.

Professional selection of sustainable assets requires aligning a business's market value with actual sales volume to avoid overpaying for an asset. By analyzing the price/sales multiple, an investor assesses the ratio of market capitalization to annual revenue, which is particularly critical for Sight Sciences, Inc. (SGHT), where high R&D expenditures and the development of OMNI systems make this metric a key indicator of the effectiveness of innovation commercialization.

Competitors of Sight Sciences, Inc.

Market Cap to Revenue Boston Scientific Corporation BSX|P/S Multiple EW (Edwards Lifesciences)|ResMed Corp (RMD) - Price to Sales|Insulet Corp - P/S Multiple|ZBH (zimmerbiomet.com) - Market Cap to Revenue Ratio|COO: P/S Multiple|Market Cap to Revenue Ratio ALGN|GMED (NuVasive) - P/S Multiple|TransMedics Corp (TMDX) - Price-to-Revenue Coefficient|P/S Multiple ATEC|Market Cap to Revenue Artivion, Inc. AORT|P/S Multiple ENOV (enovis.com)|P/S Multiple Integra LifeSciences Corp IART|ESTA - Price-to-Revenue Ratio|BBNX: Price-to-Revenue Ratio|IRMD (IRADIMED CORPORATION) - Market Cap to Revenue|Embecta Corp. - Market Capitalization-to-Revenue Ratio|TNDM (Tandem Corp) - P/S Multiple|Price to Sales AxoGen Inc AXGN|Price-to-Revenue Ratio SI-BONE Inc (SIBN)|Orthofix Medical Inc. (OFIX) - Price-to-Revenue Multiple|P/S Multiple BVS (bioventus.com)|P/S Multiple OrthoPediatrics Inc. KIDS|Treace Medical Concepts Inc - P/S Multiple|Price-to-Revenue Coefficient Blade Air Mobility SRTA|Carlsmed (CARL) - Price-to-Revenue Ratio|Price-to-Sales Ratio RXST (RxSight Ophthalmic)|Price-to-Revenue Ratio clearpointneuro.com|Market Cap to Revenue Stereotaxis, Inc. (STXS)|P/S Multiple STIM|OBIO - Price to Sales|Price-to-Revenue Ratio anikatherapeutics.com ANIK|NSPR: Market Cap to Revenue Ratio|ZJYL: Market Cap to Revenue|Vivani Medical Inc - Market Cap to Sales Volume|XTNT (Xtant Medical Holdings) - Market Cap to Revenue|Market Cap to Revenue Ratio NMTC|Price-to-Revenue Ratio Modular Medical Inc|Price to Sales Myomo Inc MYO|Market Cap to Revenue COCH (Envoy Medical, Inc.)|Price-to-Revenue Ratio VVOS (vivoslife.com)|enVVeno Medical Corp. - Market Cap to Revenue|Market Cap to Sales Volume SINT (sintx.com)|TNON - Price-to-Revenue Ratio|LFWD: Price-to-Revenue Ratio|autonomix.com (AMIX) - Price-to-Revenue Ratio|Price to Sales invobioscience.com (IVF)|BBLG (Bone Biologics Corp.) - P/S Multiple|Axonics Modulation Technologies (AXNX) - Price-to-Revenue Coefficient|Market Cap to Revenue BIOL (Biolase, Inc.)|Dynatronics - Market Cap to Revenue Ratio|Paragon 28, Inc. - Market Cap to Revenue|Price-to-Revenue Coefficient INVO Bio (INVO)